These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6541494)

  • 21. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pravastatin on serum lipids and apolipoproteins in hyperlipidemia of the nephrotic syndrome.
    Tokoo M; Oguchi H; Terashima M; Tokunaga S; Miyasaka M; Hora K; Higuchi M; Yoshie T; Furuta S
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):397-403. PubMed ID: 1635284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-marketing surveillance of probucol (Sinlestal) in Japan.
    Kosasayama A; Yoshida M; Okada S
    Artery; 1992; 19(3):147-61. PubMed ID: 1637256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M; Salamatullah Q; Ferdous Z; Hussain MA
    Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intravenous injection of CDP-choline, S-adenosyl-methionine and citiolone in subjects with hyperlipemia.
    Galeone F; Salvadorini F; Guarguaglini M; Saba P
    Artery; 1979 Feb; 5(2):157-69. PubMed ID: 231953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of hyperlipidemia. Clinical experience with clinofibrate].
    Avellone G; Di Garbo V; Strano A
    Clin Ter; 1989 Apr; 129(1):25-9. PubMed ID: 2525449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological study of nine antimicrotubular drugs with acrylophenone structure on Triton WR 1339-induced hyperlipidemia in rats.
    Brunet C; Luyckx M; Cazin M; Lesieur I; Lesieur D; Lespagnol C; Delacourte A; Mallevais ML
    Methods Find Exp Clin Pharmacol; 1985 Nov; 7(11):579-83. PubMed ID: 4087977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of alpha/beta blockers on serum lipids.
    Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):228-30. PubMed ID: 6114045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of polychlorinated biphenyls and lipemia on serum analytes.
    Steinberg KK; Freni-Titulaer LW; Rogers TN; Burse VW; Mueller PW; Stehr PA; Miller DT; Steele G
    J Toxicol Environ Health; 1986; 19(3):369-81. PubMed ID: 3021964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C; Quadri A; Ratti S; Levi GF; Prandini BD
    G Ital Cardiol; 1978; 8(7):743-51. PubMed ID: 355033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of tibric acid (CP-18.254) on plasma lipids in patients with primary endogenous hyperlipoproteinemia].
    Lisch HJ; Sailer S; Braunsteiner H
    Arzneimittelforschung; 1977; 27(10):2017-20. PubMed ID: 579116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum HDL-cholesterol-increasing and fatty liver-improving actions of Panax ginseng in high cholesterol diet-fed rats with clinical effect on hyperlipidemia in man.
    Yamamoto M; Uemura T; Nakama S; Uemiya M; Kumagai A
    Am J Chin Med; 1983; 11(1-4):96-101. PubMed ID: 6660221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in high-density lipoproteins during the acute phase of acute myocardial infarction].
    Joven J; Rubiés-Prat J; Masdeu S; de la Figuera M; Chacón P
    Med Clin (Barc); 1985 Feb; 84(4):135-7. PubMed ID: 3982108
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum lipids and eggs.
    Flynn MA; Nolph GB; Osio Y; Sun GY; Lanning B; Krause G; Dally JC
    J Am Diet Assoc; 1986 Nov; 86(11):1541-8. PubMed ID: 3771966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P; Motolese M; Cerqua R; Mancini M
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract]   [Full Text] [Related]  

  • 36. Metronidazole and serum lipids.
    Ducobu J; Fontaine C
    Artery; 1986; 13(5):264-6. PubMed ID: 3741156
    [No Abstract]   [Full Text] [Related]  

  • 37. Phospholipid composition of high-density lipoproteins reflects lipolysis of triglyceride-rich lipoproteins during hyperlipidemia.
    Perova NV; Ozerova IN; Paramonova IV; Olfer'ev AM; Akhmedzhanov NM; Pavlova LI; Oganov RG
    Bull Exp Biol Med; 2001 Apr; 131(4):321-4. PubMed ID: 11550015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of oral soybean phospholipid on serum total cholesterol, plasma triglyceride, and serum high-density lipoprotein cholesterol concentrations in hyperlipidemia.
    Ovesen L; Ebbesen K; Olesen ES
    JPEN J Parenter Enteral Nutr; 1985; 9(6):716-9. PubMed ID: 3906163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypolipodemic action of zhikeqing].
    Jiang X; Hong T; Liu W; Li F
    Zhongguo Zhong Yao Za Zhi; 1992 Jan; 17(1):45-7, inside back cover. PubMed ID: 1524669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of benzbromarone on hyperlipidemia in gout].
    Marinchev L; Kŭnev K
    Vutr Boles; 1990; 29(5):99-102. PubMed ID: 2080622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.